ICVX / Icosavax, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Icosavax, Inc.
US ˙ NasdaqGS ˙ US45114M1099
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

Ações de Insider11,690,268 shares
Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

N/A

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

N/A

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

Icosavax, Inc. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider Lucro Médio (%) Ações
Possuídas
Ajuste
de Divisão

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em ICVX / Icosavax, Inc.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custo Dias até
Máx
Preço em
Máx
Lucro
Máximo ($)
Retorno Máximo (%)
2022-04-01 MCDADE MARK 42,225 7.1000 42,225 7.1000 299,798 301 11.5100 186,213 62.11
2022-03-29 RA CAPITAL MANAGEMENT, LLC 8,900 4.7496 8,900 4.7496 42,271
2022-03-28 RA CAPITAL MANAGEMENT, LLC 175,318 4.5324 175,318 4.5324 794,611
2021-08-02 Kanesa-thasan Niranjan 6,666 15.0000 6,666 15.0000 99,990
2021-08-02 Qiming U.S. Healthcare Fund II, L.P. 13,333 15.0000 13,333 15.0000 199,995
2021-08-02 Qiming U.S. Healthcare Fund II, L.P. 8,018 15.0000 8,018 15.0000 120,270
2021-08-02 Qiming U.S. Healthcare Fund II, L.P. 200,000 15.0000 200,000 15.0000 3,000,000
2021-08-02 RA CAPITAL MANAGEMENT, LLC 171,766 15.0000 171,766 15.0000 2,576,490
2021-08-02 RA CAPITAL MANAGEMENT, LLC 2,494,900 15.0000 2,494,900 15.0000 37,423,500

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

ICVX / Icosavax, Inc. Insider Trades
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em ICVX / Icosavax, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custo Dias até
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2023-12-21 Simpson Adam K. 40,000 15.4265 40,000 15.4265 617,060 33 15.2000 -9,060 -1.47
2023-12-20 Russo Thomas Joseph 4,430 15.4650 4,430 15.4650 68,510
2023-01-04 Kanesa-thasan Niranjan 106,373 15.7038 106,373 15.7038 1,670,460
2022-12-15 Holtzman Douglas 19,648 11.1443 19,648 11.1443 218,963

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

ICVX / Icosavax, Inc. Insider Trades
Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo
Data
Data da
Operação
Formulário Insider Ticker Título de Segurança Código 10b5-1 Direto Preço de Exercício
Preço Unitário
Preço por
Unidade
Unidades
Alteradas
Valor
Alterado (1K)
Opções
Restantes
Ações
Restantes
2024-02-20 2024-02-19 4 RA CAPITAL MANAGEMENT, LLC ICVX Common Stock U - Other I -638,668 0
2024-02-20 2024-02-19 4 RA CAPITAL MANAGEMENT, LLC ICVX Common Stock U - Other I -5,324,897 0
2024-02-20 2024-02-19 4 RA CAPITAL MANAGEMENT, LLC ICVX Common Stock U - Other I -5,543 0
2024-02-20 2024-02-19 4 Simpson Adam K. By family Trust ICVX Common Stock U - Other I -129,032 0
2024-02-20 2024-02-19 4 Simpson Adam K. By family Trust ICVX Common Stock U - Other I -129,032 0
2024-02-20 2024-02-19 4 Simpson Adam K. By family Trust ICVX Common Stock U - Other I -525,044 0
2024-02-20 2024-02-19 4 Simpson Adam K. ICVX Common Stock U - Other D -358,657 0
2024-02-20 2024-02-19 4 Veneman Ann M ICVX Common Stock D - Sale to Issuer D -2,834 0
2024-02-20 2024-02-19 4 Veneman Ann M ICVX Common Stock U - Other D -11,209 0
2024-02-20 2024-02-19 4 Cearley Cassia ICVX Common Stock U - Other D -131,799 0
2024-02-20 2024-02-19 4 FIELDS HEIDI ICVX Common Stock D - Sale to Issuer D -2,917 0
2024-02-20 2024-02-19 4 FIELDS HEIDI ICVX Common Stock U - Other D -11,376 0
2024-02-20 2024-02-19 4 Wassil Jim ICVX Common Stock D - Sale to Issuer D -7,392 0
2024-02-20 2024-02-19 4 Wassil Jim ICVX Common Stock U - Other D -3,695 0
2024-02-20 2024-02-19 4 Russo Thomas Joseph ICVX Common Stock U - Other D -39,367 0
2024-02-20 2024-02-19 4 Shiver John W. ICVX Common Stock D - Sale to Issuer D -2,833 0
2024-02-20 2024-02-19 4 Shiver John W. ICVX Common Stock U - Other D -8,066 0
2024-02-20 2024-02-19 4 MCDADE MARK By Qiming U.S. Healthcare Fund II, L.P. ICVX Common Stock U - Other I -3,510,228 0
2024-02-20 2024-02-19 4 MCDADE MARK ICVX Common Stock U - Other D -55,786 0
2024-02-20 2024-02-19 4 Kanesa-thasan Niranjan ICVX Common Stock U - Other D -223,980 0
2024-02-02 2024-02-01 4 Simpson Adam K. ICVX Common Stock S - Sale D 15.2924 -15,000 -229 358,657
2024-02-02 2024-02-01 4 Simpson Adam K. ICVX Common Stock M - Exercise D 1.0400 15,000 16 373,657
2024-02-02 2024-02-01 4 Simpson Adam K. By family trust ICVX Common Stock G - Gift I -6,532 525,044
2024-01-23 2024-01-22 4 Simpson Adam K. ICVX Common Stock M - Exercise D 1.0400 93,227 97 358,657
2024-01-23 2024-01-22 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 4,789 4 265,430
2024-01-05 2023-01-04 4 Kanesa-thasan Niranjan ICVX Common Stock S - Sale D 15.7038 -106,373 -1,670 223,980
2024-01-05 2023-01-04 4 Kanesa-thasan Niranjan ICVX Common Stock M - Exercise D 15.0000 5,972 90 330,353
2024-01-05 2023-01-04 4 Kanesa-thasan Niranjan ICVX Common Stock M - Exercise D 5.9000 11,947 70 324,381
2024-01-05 2023-01-04 4 Kanesa-thasan Niranjan ICVX Common Stock M - Exercise D 1.0400 74,648 78 312,434
2024-01-05 2023-01-04 4 Kanesa-thasan Niranjan ICVX Common Stock M - Exercise D 0.8400 13,806 12 237,786
2024-01-04 2024-01-02 4 Simpson Adam K. ICVX Common Stock S - Sale D 15.6725 -15,000 -235 260,641
2024-01-04 2024-01-02 4 Simpson Adam K. ICVX Common Stock M - Exercise D 1.0400 15,000 16 275,641
2023-12-22 2023-12-21 4 Simpson Adam K. ICVX Common Stock S - Sale D 15.4265 -40,000 -617 260,641
2023-12-22 2023-12-21 4 Simpson Adam K. ICVX Common Stock S - Sale D 15.4444 -50,000 -772 300,641
2023-12-22 2023-12-21 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 23,343 20 350,641
2023-12-22 2023-12-21 4 Simpson Adam K. ICVX Common Stock M - Exercise D 2.4700 40,000 99 327,298
2023-12-22 2023-12-21 4 Simpson Adam K. ICVX Common Stock M - Exercise D 1.0400 102,574 107 287,298
2023-12-22 2023-12-20 4 Simpson Adam K. ICVX Common Stock S - Sale D 15.4571 -62,205 -962 184,724
2023-12-22 2023-12-20 4 Russo Thomas Joseph ICVX Common Stock S - Sale D 15.4650 -4,430 -69 38,037
2023-12-22 2023-12-20 4 Russo Thomas Joseph ICVX Common Stock S - Sale D 15.4571 -10,753 -166 42,467
2023-12-22 2023-12-20 4 Kanesa-thasan Niranjan ICVX Common Stock S - Sale D 15.4571 -11,884 -184 223,980
2023-12-22 2023-12-20 4 Cearley Cassia ICVX Common Stock S - Sale D 15.4571 -7,934 -123 130,694
2023-12-15 2023-12-13 4 Cearley Cassia ICVX Common Stock S - Sale D 16.0053 -8,759 -140 131,200
2023-08-01 2023-08-01 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 3,000 3 246,930
2023-08-01 2023-07-31 4 Kanesa-thasan Niranjan ICVX Common Stock S - Sale D 8.8615 -3,323 -29 235,864
2023-08-01 2023-07-31 4 Simpson Adam K. ICVX Common Stock S - Sale D 8.8615 -11,788 -104 243,930
2023-08-01 2023-07-31 4 Russo Thomas Joseph ICVX Common Stock S - Sale D 8.8615 -3,066 -27 45,620
2023-08-01 2023-07-31 4 Cearley Cassia ICVX Common Stock S - Sale D 8.8615 -1,888 -17 139,959
2023-07-03 2023-07-03 4 Holtzman Douglas ICVX Common Stock S - Sale D 9.5862 -2,095 -20 290,054
2023-07-03 2023-07-03 4 Holtzman Douglas ICVX Common Stock S - Sale D 8.7413 -14,261 -125 292,149
2023-07-03 2023-07-03 4 Holtzman Douglas ICVX Common Stock M - Exercise D 1.0400 16,356 17 306,410
2023-05-25 2023-05-23 4 Cearley Cassia ICVX Common Stock S - Sale D 10.0000 -10,000 -100 141,847
2023-04-05 2023-04-03 4 Holtzman Douglas ICVX Common Stock S - Sale D 6.5600 -300 -2 290,054
2023-04-05 2023-04-03 4 Holtzman Douglas ICVX Common Stock S - Sale D 6.0785 -20,143 -122 290,354
2023-04-05 2023-04-03 4 Holtzman Douglas ICVX Common Stock M - Exercise D 1.0400 20,443 21 310,497
2023-03-08 2023-03-06 4 Cearley Cassia ICVX Common Stock S - Sale D 7.7474 -5,000 -39 151,847
2023-02-16 2023-02-15 4 Simpson Adam K. ICVX Common Stock M - Exercise D 1.0400 10,677 11 255,718
2023-02-15 2023-02-13 4 Bekiroglu Elizabeth ICVX Common Stock S - Sale D 10.6926 -5,922 -63 103,007
2023-02-15 2023-02-14 4 Holtzman Douglas ICVX Common Stock S - Sale D 10.1715 -3,349 -34 290,054
2023-02-15 2023-02-13 4 Holtzman Douglas ICVX Common Stock S - Sale D 10.6926 -1,522 -16 293,403
2023-02-15 2023-02-13 4 Simpson Adam K. ICVX Common Stock S - Sale D 10.6926 -7,506 -80 245,041
2023-02-15 2023-02-13 4 Russo Thomas Joseph ICVX Common Stock S - Sale D 10.6926 -1,902 -20 48,686
2023-02-15 2023-02-13 4 Kanesa-thasan Niranjan ICVX Common Stock S - Sale D 10.6926 -1,794 -19 239,187
2023-02-15 2023-02-13 4 Cearley Cassia ICVX Common Stock S - Sale D 10.6926 -1,660 -18 156,847
2023-02-14 2022-05-31 5 Russo Thomas Joseph ICVX Common Stock A - Award D 5.7700 1,667 10 50,588
2023-02-14 2022-05-31 5 Kanesa-thasan Niranjan ICVX Common Stock A - Award D 5.7700 1,667 10 240,981
2023-02-14 2022-05-31 5 Holtzman Douglas ICVX Common Stock A - Award D 5.7700 1,667 10 294,925
2023-02-14 2022-05-31 5 Cearley Cassia ICVX Common Stock A - Award D 5.7700 1,667 10 158,507
2023-01-31 2023-01-30 4 Cearley Cassia ICVX Common Stock M - Exercise D 0.8400 25,102 21 156,840
2023-01-27 2023-01-25 4 Simpson Adam K. ICVX Common Stock M - Exercise D 1.0400 10,678 11 252,547
2023-01-27 2023-01-25 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 2,395 2 241,869
2022-12-23 2022-12-23 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 14,369 12 239,474
2022-12-23 2022-12-21 4 Simpson Adam K. ICVX Common Stock S - Sale D 8.9630 -66,764 -598 225,105
2022-12-16 2022-12-15 4 Holtzman Douglas By Stanley Holtzman ICVX Common Stock S - Sale I 11.1443 -19,648 -219 2,792
2022-09-09 2022-09-08 4 Bekiroglu Elizabeth ICVX Common Stock S - Sale D 4.8731 -1,813 -9 108,929
2022-08-02 2022-08-02 4 Cearley Cassia ICVX Common Stock S - Sale D 6.7038 -303 -2 131,738
2022-08-02 2022-08-01 4 Cearley Cassia ICVX Common Stock S - Sale D 6.6374 -1,118 -7 132,041
2022-08-02 2022-07-29 4 Cearley Cassia ICVX Common Stock S - Sale D 7.1076 -391 -3 133,159
2022-08-02 2022-08-02 4 Russo Thomas Joseph ICVX Common Stock S - Sale D 6.7038 -495 -3 48,921
2022-08-02 2022-08-01 4 Russo Thomas Joseph ICVX Common Stock S - Sale D 6.6374 -1,825 -12 49,416
2022-08-02 2022-07-29 4 Russo Thomas Joseph ICVX Common Stock S - Sale D 7.1076 -639 -5 51,241
2022-08-02 2022-08-02 4 Kanesa-thasan Niranjan ICVX Common Stock S - Sale D 6.7038 -543 -4 239,314
2022-08-02 2022-08-01 4 Kanesa-thasan Niranjan ICVX Common Stock S - Sale D 6.6374 -2,001 -13 239,857
2022-08-02 2022-07-29 4 Kanesa-thasan Niranjan ICVX Common Stock S - Sale D 7.1076 -701 -5 241,858
2022-08-02 2022-08-02 4 Holtzman Douglas ICVX Common Stock S - Sale D 6.7038 -453 -3 293,258
2022-08-02 2022-08-01 4 Holtzman Douglas ICVX Common Stock S - Sale D 6.6374 -9,337 -62 293,711
2022-08-02 2022-07-29 4 Holtzman Douglas ICVX Common Stock S - Sale D 7.1076 -585 -4 303,048
2022-08-02 2022-02-18 4 Holtzman Douglas By Stanley Holtzman ICVX Common Stock G - Gift I -20,000 22,440
2022-08-02 2022-08-02 4 Simpson Adam K. ICVX Common Stock S - Sale D 6.7038 -1,904 -13 291,869
2022-08-02 2022-08-01 4 Simpson Adam K. ICVX Common Stock S - Sale D 6.6374 -7,017 -47 293,772
2022-08-02 2022-07-29 4 Simpson Adam K. ICVX Common Stock S - Sale D 7.1076 -2,456 -17 300,789
2022-08-02 2022-08-02 4 Richardson Charles E ICVX Common Stock S - Sale D 6.7038 -371 -2 165,168
2022-08-02 2022-08-01 4 Richardson Charles E ICVX Common Stock S - Sale D 6.6374 -1,368 -9 165,539
2022-08-02 2022-07-29 4 Richardson Charles E ICVX Common Stock S - Sale D 7.1076 -479 -3 166,907
2022-07-06 2022-07-01 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 7,185 6 303,245
2022-06-14 2022-06-10 4 Wassil Jim ICVX Common Stock A - Award D 11,087 11,087
2022-06-14 2022-06-10 4 Veneman Ann M ICVX Common Stock A - Award D 5,543 14,043
2022-06-14 2022-06-10 4 Shiver John W. ICVX Common Stock A - Award D 2,399 10,899
2022-06-14 2022-06-10 4 FIELDS HEIDI ICVX Common Stock A - Award D 5,543 14,293
2022-06-14 2022-06-10 4 RA CAPITAL MANAGEMENT, LLC ICVX Common Stock A - Award I 5,543 5,543
2022-06-14 2022-06-10 4 MCDADE MARK ICVX Common Stock A - Award D 5,543 55,786
2022-04-05 2022-04-01 4 MCDADE MARK ICVX Common Stock P - Purchase D 7.1000 42,225 300 50,243
2022-03-30 2022-03-28 4 Simpson Adam K. ICVX Stock Option (Right to Buy) M - Exercise D 0.84 -4,789 55,081
2022-03-30 2022-03-28 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 4,789 4 220,482
2022-03-30 2022-03-29 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Common Stock P - Purchase I 4.7496 8,900 42 5,963,565
2022-03-30 2022-03-28 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Common Stock P - Purchase I 4.5324 175,318 795 5,953,665
2022-03-22 2022-03-18 4 Cearley Cassia ICVX Stock Option (Right to Buy) M - Exercise D 0.84 -35,137 27,613
2022-03-22 2022-03-18 4 Cearley Cassia ICVX Common Stock M - Exercise D 0.8400 35,137 30 133,550
2022-03-09 2022-03-07 4 Cearley Cassia ICVX Common Stock S - Sale D 17.8100 -484 -9 98,413
2022-03-09 2022-03-07 4 Cearley Cassia ICVX Common Stock S - Sale D 17.1300 -9,516 -163 98,897
2022-02-16 2022-02-14 4 Richardson Charles E ICVX Stock Option (Right to Buy) M - Exercise D 1.04 -6,186 16,657
2022-02-16 2022-02-14 4 Richardson Charles E ICVX Stock Option (Right to Buy) M - Exercise D 0.84 -66,375 43,489
2022-02-16 2022-02-14 4 Richardson Charles E ICVX Common Stock M - Exercise D 1.0400 6,186 6 167,386
2022-02-16 2022-02-14 4 Richardson Charles E ICVX Common Stock M - Exercise D 0.8400 66,375 56 161,200
2022-02-14 2022-02-10 4 Simpson Adam K. ICVX Stock Option (Right to Buy) A - Award D 17.55 317,866 317,866
2022-02-14 2022-02-10 4 Simpson Adam K. ICVX Common Stock A - Award D 75,578 291,271
2022-02-14 2022-02-10 4 Russo Thomas Joseph ICVX Stock Option (Right to Buy) A - Award D 17.55 74,500 74,500
2022-02-14 2022-02-10 4 Russo Thomas Joseph ICVX Common Stock A - Award D 17,714 51,880
2022-02-14 2022-02-10 4 Kanesa-thasan Niranjan ICVX Stock Option A - Award D 17.55 81,950 81,950
2022-02-14 2022-02-10 4 Kanesa-thasan Niranjan ICVX Common Stock A - Award D 19,485 242,559
2022-02-14 2022-02-10 4 Richardson Charles E ICVX Stock Option (Right to Buy) A - Award D 17.55 67,050 67,050
2022-02-14 2022-02-10 4 Richardson Charles E ICVX Common Stock A - Award D 15,942 94,825
2022-02-14 2022-02-10 4 Holtzman Douglas ICVX Stock Option (Right to Buy) A - Award D 17.55 81,950 81,950
2022-02-14 2022-02-10 4 Holtzman Douglas ICVX Common Stock A - Award D 19,485 303,633
2022-02-14 2021-12-31 4 Holtzman Douglas By Stanley Holtzman ICVX Common Stock G - Gift I -10,000 42,440
2022-02-14 2022-02-10 4 Bekiroglu Elizabeth ICVX Common Stock A - Award D 82,992 110,742
2022-02-14 2022-02-10 4 Cearley Cassia ICVX Stock Option (Right to Buy) A - Award D 17.55 89,400 89,400
2022-02-14 2022-02-10 4 Cearley Cassia ICVX Common Stock A - Award D 21,256 108,413
2022-02-04 2022-02-02 4 Kanesa-thasan Niranjan ICVX Stock Option Right to Buy) M - Exercise D 1.04 -38,947 116,841
2022-02-04 2022-02-02 4 Kanesa-thasan Niranjan ICVX Stock Option (Right to Buy) M - Exercise D 0.84 -13,805 16,317
2022-02-04 2022-02-02 4 Kanesa-thasan Niranjan ICVX Common Stock M - Exercise D 1.0400 38,947 41 221,408
2022-02-04 2022-02-02 4 Kanesa-thasan Niranjan ICVX Common Stock M - Exercise D 0.8400 13,805 12 182,461
2022-01-28 2022-01-26 4 Simpson Adam K. ICVX Stock Option (Right to Buy) M - Exercise D 1.04 -73,929 438,605
2022-01-28 2022-01-26 4 Simpson Adam K. ICVX Stock Option (Right to Buy) M - Exercise D 0.84 -16,764 59,870
2022-01-28 2022-01-26 4 Simpson Adam K. ICVX Common Stock M - Exercise D 1.0400 73,929 77 215,693
2022-01-28 2022-01-26 4 Simpson Adam K. ICVX Common Stock M - Exercise D 0.8400 16,764 14 141,764
2022-01-28 2021-12-21 4 Simpson Adam K. By family trust ICVX Common Stock G - Gift I 125,000 129,032
2022-01-28 2021-12-21 4 Simpson Adam K. By family trust ICVX Common Stock G - Gift I 125,000 129,032
2022-01-28 2021-12-21 4 Simpson Adam K. By family trust ICVX Common Stock G - Gift I -125,000 531,576
2022-01-28 2021-12-21 4 Simpson Adam K. By family trust ICVX Common Stock G - Gift I -125,000 531,576
2022-01-05 2022-01-03 4 Shiver John W. ICVX Stock Option (Right to Buy) A - Award D 22.50 25,500 25,500
2022-01-05 2022-01-03 4 Shiver John W. ICVX Common Stock A - Award D 8,500 8,500
2021-11-17 2021-11-15 4 Cearley Cassia ICVX Stock Option (Right to Buy) M - Exercise D 0.83 -22,598 62,750
2021-11-17 2021-11-15 4 Cearley Cassia ICVX Common Stock M - Exercise D 0.8300 22,598 19 85,491
2021-09-21 3 Bekiroglu Elizabeth ICVX Common Stock D 27,750
2021-08-04 2021-08-02 4 NanoDimension III, L.P. ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -1,027,741 0
2021-08-04 2021-08-02 4 NanoDimension III, L.P. ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -10,400,415 0
2021-08-04 2021-08-02 4 NanoDimension III, L.P. ICVX Common Stock P - Purchase D 15.0000 133,334 2,000 2,883,329
2021-08-04 2021-08-02 4 NanoDimension III, L.P. ICVX Common Stock C - Conversion D 2,749,995 2,749,995
2021-08-04 2021-08-02 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I -1,940,306 0
2021-08-04 2021-08-02 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I -10,995,066 0
2021-08-04 2021-08-02 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Common Stock P - Purchase I 15.0000 171,766 2,576 638,668
2021-08-04 2021-08-02 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Common Stock C - Conversion I 466,902 466,902
2021-08-04 2021-08-02 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Common Stock P - Purchase I 15.0000 2,494,900 37,424 5,140,679
2021-08-04 2021-08-02 4 RA CAPITAL MANAGEMENT, LLC See footnotes ICVX Common Stock C - Conversion I 2,645,779 2,645,779
2021-08-04 2021-08-02 4 Cormorant Asset Management, LLC See Footnotes ICVX Series B-1 Convertible Preferred Stock C - Conversion I -426,393 0
2021-08-04 2021-08-02 4 Cormorant Asset Management, LLC See Footnotes ICVX Common Stock C - Conversion I 426,393 426,393
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -79,734 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -171,505 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -114,843 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -88,775 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -299,003 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -309,321 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -935,985 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -2,013,269 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -1,348,119 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -1,042,120 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -3,509,939 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -3,631,066 0
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock P - Purchase I 15.0000 12,368 186 256,783
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock C - Conversion I 244,415 244,415
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock P - Purchase I 15.0000 26,604 399 552,333
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock C - Conversion I 525,729 525,729
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock C - Conversion I 352,037 352,037
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock C - Conversion I 272,131 272,131
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock P - Purchase I 15.0000 46,381 696 962,939
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock C - Conversion I 916,558 916,558
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock P - Purchase I 15.0000 47,981 720 996,169
2021-08-03 2021-08-02 4 Gould Terry P See footnotes ICVX Common Stock C - Conversion I 948,188 948,188
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -79,734 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -171,505 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -114,843 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -88,775 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -299,003 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -309,321 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -935,985 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -2,013,269 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -1,348,119 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -1,042,120 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -3,509,939 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -3,631,066 0
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock P - Purchase I 15.0000 12,368 186 256,783
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock C - Conversion I 244,415 244,415
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock P - Purchase I 15.0000 26,604 399 552,333
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock C - Conversion I 525,729 525,729
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock C - Conversion I 352,037 352,037
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock C - Conversion I 272,131 272,131
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock P - Purchase I 15.0000 46,381 696 962,939
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock C - Conversion I 916,558 916,558
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock P - Purchase I 15.0000 47,981 720 996,169
2021-08-03 2021-08-02 4 ADAMS STREET PARTNERS LLC See footnotes ICVX Common Stock C - Conversion I 948,188 948,188
2021-08-02 2021-07-30 4 FIELDS HEIDI ICVX Common Stock A - Award D 15.0000 8,750 131 8,750
2021-08-02 2021-07-30 4 Veneman Ann M ICVX Common Stock A - Award D 15.0000 8,500 128 8,500
2021-08-02 2021-08-02 4 Kanesa-thasan Niranjan ICVX Common Stock P - Purchase D 15.0000 6,666 100 6,666
2021-08-02 2021-07-30 4 Kanesa-thasan Niranjan ICVX Common Stock A - Award D 15.0000 41,500 622 168,656
2021-08-02 2021-08-02 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc ICVX Series B-1 Preferred Stock (par value, $0.0001) C - Conversion I 0.00 -354,393 0
2021-08-02 2021-08-02 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc ICVX Series A-1 Preferred Stock (par value, $0.0001) C - Conversion I 0.00 -12,480,498 0
2021-08-02 2021-08-02 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. ICVX Common Stock (par value, $0.0001) P - Purchase I 15.0000 66,667 1,000 3,155,169
2021-08-02 2021-08-02 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. ICVX Common Stock (par value, $0.0001) C - Conversion I 3,088,502 3,088,502
2021-08-02 2021-07-30 4 Russo Thomas Joseph ICVX Common Stock A - Award D 15.0000 32,500 488 32,500
2021-08-02 2021-07-30 4 Cearley Cassia ICVX Common Stock A - Award D 15.0000 27,750 416 62,893
2021-08-02 2021-08-02 4 Holtzman Douglas By Stanley Holtzman ICVX Series B-1 Preferred Stock C - Conversion I 0.00 -11,602 0
2021-08-02 2021-08-02 4 Holtzman Douglas By Stanley Holtzman ICVX Series A-1 Preferred Stock C - Conversion I 0.00 -206,323 0
2021-08-02 2021-08-02 4 Holtzman Douglas By Stanley Holtzman ICVX Common Stock C - Conversion I 52,440 52,440
2021-08-02 2021-07-30 4 Holtzman Douglas ICVX Common Stock A - Award D 15.0000 41,500 622 282,482
2021-08-02 2021-07-30 4 Richardson Charles E ICVX Common Stock A - Award D 15.0000 27,750 416 78,883
2021-08-02 2021-08-02 4 Qiming U.S. Healthcare Fund II, L.P. ICVX Series B-1 Preferred Stock C - Conversion D 0.00 -1,275,817 0
2021-08-02 2021-08-02 4 Qiming U.S. Healthcare Fund II, L.P. ICVX Series A-1 Preferred Stock C - Conversion D 0.00 -12,480,498 0
2021-08-02 2021-08-02 4 Qiming U.S. Healthcare Fund II, L.P. ICVX Common Stock P - Purchase D 15.0000 13,333 200 3,523,561
2021-08-02 2021-08-02 4 Qiming U.S. Healthcare Fund II, L.P. ICVX Common Stock P - Purchase D 15.0000 8,018 120 3,518,246
2021-08-02 2021-08-02 4 Qiming U.S. Healthcare Fund II, L.P. ICVX Common Stock P - Purchase D 15.0000 200,000 3,000 3,510,228
2021-08-02 2021-08-02 4 Qiming U.S. Healthcare Fund II, L.P. ICVX Common Stock C - Conversion D 3,310,228 3,310,228
2021-08-02 2021-07-30 4 Simpson Adam K. ICVX Common Stock A - Award D 15.0000 125,000 1,875 125,000
2021-07-28 3 Cearley Cassia ICVX Common Stock D 35,143
2021-07-28 3 Kanesa-thasan Niranjan ICVX Common Stock D 120,490
2021-07-28 3 Yamada Tadataka ICVX Common Stock D 124,097
2021-07-28 3 Yamada Tadataka By Leslie D. Yamada 2016 Trust ICVX Common Stock I 627,229
2021-07-28 3 Holtzman Douglas ICVX Common Stock D 240,982
2021-07-28 3 Richardson Charles E ICVX Common Stock D 51,133
2021-07-28 3 Simpson Adam K. By family trust ICVX Common Stock I 781,576
2021-07-28 3 Simpson Adam K. By family trust ICVX Common Stock I 4,032
2021-07-28 3 Simpson Adam K. By family trust ICVX Common Stock I 4,032
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista